ADMA Biologics Non Operating Income Net Other Over Time

ADMA Stock  USD 17.02  0.11  0.65%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out ADMA Biologics Performance and ADMA Biologics Correlation.
For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.
  
The current year's Non Operating Income Net Other is expected to grow to about (6.2 M).
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADMA Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
14
Earnings Share
0.81
Revenue Per Share
1.83
Quarterly Revenue Growth
0.591
Return On Assets
0.2124
The market value of ADMA Biologics is measured differently than its book value, which is the value of ADMA that is recorded on the company's balance sheet. Investors also form their own opinion of ADMA Biologics' value that differs from its market value or its book value, called intrinsic value, which is ADMA Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADMA Biologics' market value can be influenced by many factors that don't directly affect ADMA Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADMA Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADMA Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Non Operating Income Net Other Analysis

Compare ADMA Biologics and related stocks such as Atara Biotherapeutics, Fate Therapeutics, and Sana Biotechnology Non Operating Income Net Other Over Time
Select Fundamental
Price To Sales RatioPtb Ratio
Capex To DepreciationPb Ratio
RoicInventory Turnover
Net Income Per SharePayables Turnover
Sales General And Administrative To RevenueResearch And Ddevelopement To Revenue
PocfratioInterest Coverage
Capex To Operating Cash FlowPfcf Ratio
Income QualityRoe
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Current RatioReceivables Turnover
Debt To EquityRevenue Per Share
Debt To AssetsDividend Yield
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueEv To Sales
Free Cash Flow Per ShareDays Of Inventory On Hand
Average InventoryCapex To Revenue
Cash Per SharePayout Ratio
Days Payables OutstandingNet Current Asset Value
Tangible Asset ValueNet Debt To E B I T D A
Tangible Book Value Per ShareShareholders Equity Per Share
Capex Per ShareGraham Net Net
Average ReceivablesInterest Debt Per Share
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioPrice Book Value Ratio
Price Earnings To Growth RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
Operating CycleDays Of Payables Outstanding
Dividend Payout RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingEnterprise Value Multiple
2010201120122013201420152016201720182019202020212022202320242025
ATRA125 K125 K125 K125 K125 K1.2 M2.2 MM6.4 M4.7 M2.4 M367 K52.2 M52.2 M60.1 M63.1 M
FATE(3.2 M)(3.2 M)(3.2 M)(3.2 M)(979 K)(2.2 M)(1.5 M)(827 K)494 K2.6 M(45.3 M)4.8 M4.8 M4.8 M4.4 M4.6 M
SANA305 K305 K305 K305 K305 K305 K305 K305 K305 K305 K305 K305 K(674 K)(674 K)(606.6 K)(576.3 K)
CRBU250 K250 K250 K250 K250 K250 K250 K250 K250 K250 K250 K250 KMM8.1 M8.5 M
RCUS5.3 M5.3 M5.3 M5.3 M5.3 M5.3 M5.3 M5.3 M5.3 MM1.4 M397 K397 K397 K357.3 K339.4 K
INMB77.7 K77.7 K77.7 K77.7 K77.7 K77.7 K77.7 K77.7 K77.7 K77.7 K128.5 K(1.2 M)(1.2 M)(1.2 M)(1.1 M)(1 M)
ETNB(203 K)(203 K)(203 K)(203 K)(203 K)(203 K)(203 K)(203 K)(203 K)(203 K)(203 K)2.2 M2.2 M2.2 M2.5 M2.6 M
MDGL48.3 K48.3 K48.3 K48.3 K48.3 K48.3 K48.3 K558 K7.7 M11 M4.3 M363 K2.2 M2.2 M2.5 M4.1 M
PLRX112 K112 K112 K112 K112 K112 K112 K112 K112 K112 K112 K272 K3.9 M3.9 M4.5 M4.7 M
STOK801 K801 K801 K801 K801 K801 K801 K801 K801 K801 K801 K140 K167 K167 K150.3 K295.5 K
PLXKK554 K(674 K)(4.7 M)(3.6 M)M(48.9 M)(7.1 M)(7.6 M)(7.6 M)(7.6 M)(7.6 M)(7.6 M)(6.8 M)(7.1 M)
CDTX271 K271 K271 K271 K271 K271 K271 K(7 K)4.3 M632 K(262 K)191 K191 K191 K171.9 K163.3 K
AKBA287 K287 K287 K287 K287 K287 K713 K204 K81 K(794 K)1.9 M2.4 M2.2 M2.2 M2.6 M2.7 M
XFOR579 K579 K579 K579 K579 K579 K579 K579 K579 K579 K579 K(2.3 M)(2.3 M)(2.3 M)(2 M)(1.9 M)
MCRB631 K631 K631 K631 K631 K631 K2.2 M425 K170 K2.1 M1.9 M1.8 M2.4 M2.4 M2.7 M1.6 M
VXRT231 K231 K200 K200 K200 K(200 K)(1.6 M)4.7 M4.7 M(2.2 M)(13 K)(1000)(6 K)(6 K)(5.4 K)(5.1 K)
IBIO559 K559 K559 K174 K41 K43 K64 K34 K91 K25 K25 K25 K25 K25 K22.5 K21.4 K
TNXP(1.2 M)(1.2 M)(1.2 M)127 K127 K127 K127 K168 K233 K210 K48 K25 K25 K25 K28.8 K30.2 K
BCRX(3.6 M)(3.6 M)(527 K)5.4 M5.6 M1.6 M(50 K)194 K2.1 M2.5 M(3 M)55.1 M55.1 M55.1 M63.4 M66.6 M

ADMA Biologics and related stocks such as Atara Biotherapeutics, Fate Therapeutics, and Sana Biotechnology Non Operating Income Net Other description

My Equities

My Current Equities and Potential Positions

ADMA Biologics
ADMA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationNew Jersey; U.S.A
ExchangeNASDAQ Exchange
USD 17.02
When determining whether ADMA Biologics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ADMA Biologics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Adma Biologics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Adma Biologics Stock:
Check out ADMA Biologics Performance and ADMA Biologics Correlation.
For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
ADMA Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of ADMA Biologics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ADMA Biologics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...